In This Store
Including the apis and premix).
Company existing staff 500 people, has fine chemical, biological fermentation, animal health and so on GMP production base of 33 acres.
Successively won the Chinese high-tech enterprises, innovative pilot enterprises in zhejiang province, zhejiang patent demonstration enterprises, etc.
Is Esigma animal medicine association and China feed economic committee, deputy director of the unit.
The two series products - growth promoter and coccidiostat were currently provided by Esigma. Nonon (Nosiheptide Premix) which is the global leader was listed as the national key new product in 2011. And our market share of coccidiostat ranked first in China. For more than ten years, the products of Esigma have been sold well over 30 provinces and cities in China and more than 20 countries around the world.
The stable development of Esigma can hardly do without the support of all sectors of the community and cooperation of our stuff. We believe that the key of our success is to focus on research, pursuit of high quality and satisfy the customer. Esigma has researched and developed the high-tech product that our research team has undertaken 863 projects and hosted a major scientific technological project in Zhejiang province. As the first complete unit developed Nosiheptide project, Esigma won the Zhejiang Province Science and Technology Award.
"Honest and upright, people oriented, friendly and work committed, enterprising and innovative" is the core value of Esigma. We will keep focusing on customers’ demand, innovation and long-term objectives to create the future with Esigma.
Year of Establishment: 1997
Total Assets(USD):
Total Number of Staff: less than 10 person
Main Competitive Advantages:
Other Competitive Advantages: GMP certificated
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: